Cas:14408-19-6 2-(n-phenyl-n-ethyl)aminoethylpyridiniu& manufacturer & supplier

We serve Chemical Name:2-(n-phenyl-n-ethyl)aminoethylpyridiniu& CAS:14408-19-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(n-phenyl-n-ethyl)aminoethylpyridiniu&

Chemical Name:2-(n-phenyl-n-ethyl)aminoethylpyridiniu&
CAS.NO:14408-19-6
Synonyms:EINECS 238-381-2;MFCD00036054;Pyridinium,1-(2-(ethylphenylamino)ethyl)-,chloride;2-(N-Phenyl-N-ethyl)aminoethylpyridinium chloride;1-{2-[ethyl(phenyl)amino]ethyl}pyridinium chloride
Molecular Formula:C15H19ClN2
Molecular Weight:262.77800
HS Code:

Physical and Chemical Properties:
Melting point:82-86ºC(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:7.12000
Exact Mass:262.12400
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like EINECS 238-381-2 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-{2-[ethyl(phenyl)amino]ethyl}pyridinium chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(N-Phenyl-N-ethyl)aminoethylpyridinium chloride Use and application,Pyridinium,1-(2-(ethylphenylamino)ethyl)-,chloride technical grade,usp/ep/jp grade.


Related News: Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations. 2-(n-phenyl-n-ethyl)aminoethylpyridiniu& manufacturer A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns. 2-(n-phenyl-n-ethyl)aminoethylpyridiniu& supplier Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients. 2-(n-phenyl-n-ethyl)aminoethylpyridiniu& vendor But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. 2-(n-phenyl-n-ethyl)aminoethylpyridiniu& factory A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns.